Sign in

CIK 0001534969

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
261911522
Phone
+1 801-990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,563
in 6 filings

Net −$79,563. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-04-06 Boniface John J. Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −1,000 4,844
2022-04-05 Boniface John J. Chief Scientific Officer Sale −2,725 $3.35 $9K 90,110
2022-03-29 Boniface John J. Chief Scientific Officer Sale −2,725 $3.73 $10K 92,835
2022-03-23 Jackson Benjamin General Counsel Grant or award · Stock Option (right to buy) +60,345 60,345
2022-03-23 CRITCHFIELD GREGORY C Chief Executive Officer Grant or award · Stock Option (right to buy) +429,225 429,225
2022-03-23 Altomare Nadia Chief Commercial Officer Grant or award · Stock Option (right to buy) +75,735 75,735
2022-03-23 Harrison Robert Gardner Chief Information Officer Grant or award · Stock Option (right to buy) +33,698 33,698
2022-03-23 Boniface John J. Chief Scientific Officer Grant or award · Stock Option (right to buy) +121,705 121,705
2022-03-23 MOYES JAY M Chief Financial Officer Grant or award · Stock Option (right to buy) +168,275 168,275
2022-03-23 Kearney Paul Chief Data Officer Grant or award · Stock Option (right to buy) +30,426 30,426
2022-03-22 Boniface John J. Chief Scientific Officer Sale −2,725 $3.68 $10K 95,560
2022-03-14 Boniface John J. Chief Scientific Officer Sale −2,725 $3.94 $11K 98,285
2022-03-11 Boniface John J. Chief Scientific Officer Exercise or conversion +75,998 $0.73 $55K 101,010
2022-03-11 Boniface John J. Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −75,998 0
2022-01-28 Foley Michael R Chief Medical Officer Grant or award · Stock Option (right to buy) +276,000 276,000
2021-12-06 Boniface John J. Chief Scientific Officer Exercise or conversion +25,012 $0.73 $18K 25,012
2021-12-06 Boniface John J. Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −25,012 0
2021-11-29 Lawrence Sandra AJ Director Grant or award · Stock Option (right to buy) +40,332 40,332
2021-11-08 Lindgardt Zhenya Director Grant or award · Stock Option (right to buy) +38,325 38,325
2021-11-01 Kearney Paul Chief Data Officer Grant or award · Stock Option (right to buy) +107,000 107,000

Page 20 of 23 · 457 trades